Compounds for modulating integrin CD11b/CD18
    36.
    发明授权
    Compounds for modulating integrin CD11b/CD18 有权
    用于调节整合蛋白CD11b / CD18的化合物

    公开(公告)号:US08268816B2

    公开(公告)日:2012-09-18

    申请号:US12456692

    申请日:2009-06-19

    Abstract: The application describes an assay for the identification of small molecule modulators of integrin CD11b/CD18 and small molecules capable of modulating activity of this receptor. For example, one such compound useful as an agonist of integrin CD11b/CD18 is the compound of Formula (I): Such compounds may be used in certain embodiments for treating a disease or condition selected from inflammation, immune-related disorders, cancer, ischemia-reperfusion injury, stroke, neointimal thickening associated with vascular injury, bullous pemphigoid, neonatal obstructive nephropathy, and cardiovascular disease, or in other embodiments for the treatment of a disease or condition selected from immune deficiency, acquired immune deficiency syndrome (AIDS), myeloperoxidase deficiency, Wiskott-Aldrich syndrome, chronic granulomatous disease, hyper-IgM syndromes, leukocyte adhesion deficiency, Chediak-Higashi syndrome, and severe combined immunodeficiency.

    Abstract translation: 该应用描述了用于鉴定整合素CD11b / CD18的小分子调节剂和能够调节该受体活性的小分子的测定法。 例如,可用作整联蛋白CD11b / CD18的激动剂的一种这样的化合物是式(I)的化合物:这些化合物可用于某些实施方案中用于治疗选自炎症,免疫相关疾病,癌症,局部缺血的疾病或病症 - 再灌注损伤,中风,与血管损伤相关的新内膜增厚,大疱性类天疱疮,新生儿梗阻性肾病和心血管疾病,或在其它实施方案中用于治疗选自免疫缺陷,获得性免疫缺陷综合征(AIDS),髓过氧化物酶 Wiskott-Aldrich综合征,慢性肉芽肿病,超IgM综合征,白细胞粘连缺陷,Chediak-Higashi综合征和严重联合免疫缺陷。

    Methods and kits for distinguishing between specific and non-specific protein associations
    38.
    发明授权
    Methods and kits for distinguishing between specific and non-specific protein associations 有权
    用于区分特异性和非特异性蛋白质关联的方法和试剂盒

    公开(公告)号:US08227198B2

    公开(公告)日:2012-07-24

    申请号:US13106490

    申请日:2011-05-12

    Abstract: The present invention is method of determining whether or not associations between a given protein and other proteins in a cell are specific. The method comprises (a) providing a first sample of the cells in which the given protein contains a tag, (b) providing a second sample of the same cells, wherein the given protein and the other proteins are metabolically labeled, and wherein neither the given protein nor the other proteins are tagged, (c) mixing and lysing the first cell sample and the second cell sample to provide a mixture of proteins, (d) binding the tag of the given protein to a substrate, (e) isolating proteins associated with the tagged given protein bound to the substrate, whereby the associated proteins comprise: (i) proteins specifically associated with the tagged given protein, (ii) proteins non-specifically associated with the tagged given protein, or (iii) a combination thereof, (f) determining whether each associated protein is unlabeled or a mixture of labeled and unlabeled proteins, wherein if the associated protein is not labeled, then that protein was specifically associated in the cell with the tagged given protein.

    Abstract translation: 本发明是确定细胞中给定蛋白质和其它蛋白质之间的缔合是否是特异性的方法。 该方法包括(a)提供其中给定蛋白质含有标签的细胞的第一样品,(b)提供相同细胞的第二样品,其中所述给定蛋白质和其它蛋白质代谢标记,并且其中 (c)混合和裂解第一细胞样品和第二细胞样品以提供蛋白质的混合物,(d)将给定蛋白质的标签与底物结合,(e)分离蛋白质 与标记的给定蛋白质结合至底物,其中相关蛋白质包含:(i)与标记的给定蛋白质特异性相关的蛋白质,(ii)与标记的给定蛋白质非特异性相关的蛋白质,或(iii)其组合 ,(f)确定每个相关蛋白是否未标记,或标记蛋白和未标记蛋白质的混合物,其中如果相关蛋白未被标记,那么该蛋白质与标记特异性结合在细胞中 给定蛋白质。

Patent Agency Ranking